APHMX | RPMGX | APHMX / RPMGX | |
Total Expense Ratio | 0.96 | 0.75 | 128% |
Annual Report Gross Expense Ratio | 0.96 | 0.75 | 128% |
Fund Existence | 25 years | 33 years | - |
Gain YTD | 18.044 | 2.537 | 711% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.75B | 26.7B | 14% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 11.30 | -5.53 | -204% |
Returns for 3 years | 40.19 | 19.23 | 209% |
Returns for 5 years | -14.05 | -4.29 | 327% |
Returns for 10 years | 1.51 | 28.82 | 5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 72.16 | 0.53 | +0.75% |
Virtus LifeSci Biotech Products ETF | |||
JCPB | 47.45 | 0.04 | +0.08% |
JPMorgan Core Plus Bond ETF | |||
KCE | 151.18 | 0.10 | +0.07% |
SPDR® S&P Capital Markets ETF | |||
IBDZ | 26.44 | -0.01 | -0.04% |
iShares iBonds Dec 2034 Term Corp ETF | |||
SCJ | 90.90 | -0.53 | -0.58% |
iShares MSCI Japan Small-Cap ETF |